More patients are undergoing surgical procedures performed as day surgery with much of their recovery time at home without the direct supervision of a healthcare professional; therefore, these patients must possess functional health literacy (FHL) to understand instructions on how to manage their recovery at home. A new study, published in JAMA Surgery, described FHL among patients in Sweden who were undergoing day surgery and the association of FHL with postoperative recovery.
More patients are undergoing surgical procedures performed as day surgery with much of their recovery time at home without the direct supervision of a healthcare professional; therefore, these patients must possess functional health literacy (FHL) to understand instructions on how to manage their recovery at home. A new study1, published in JAMA Surgery, described FHL among patients in Sweden who were undergoing day surgery and the association of FHL with postoperative recovery.
The observational study, part of a multicenter, 2-group, parallel, single-blind randomized clinical trial conducted from 2015 to 2016 at 4 day-surgery facilities in Sweden, included 704 patients, all of whom had completed an FHL questionnaire that measured visual ability related to text design and accessibility; understanding words and concepts; the ability to persevere in reading; and the need for help in reading and understanding information. Most patients (60.6%) reported that they had sufficient FHL, 31.7% reported problematic FHL, and 54% reported that they had inadequate FHL.
In patients with problematic and inadequate FHL, quality of recovery was poorer; the group with inadequate FHL had a global quality of recovery score (measured on a scale on which 0 is excellent recovery and 240 is poor recovery) of 37.2, and the group with problematic FHL had a score of 22.9, while the group with sufficient FHL had a score of 17.7.
The most differences in recovery were found between the groups who had inadequate and sufficient FHL. Those with inadequate FHL had the following when compared with those with sufficient FHL:
Health-related quality of life, as measured by the EuroQol-visual analog scale, also revealed poorer outcomes for those with inadequate FHL; this group had worse scores for physical function, vitality, social functioning, and mental health.
“Our results suggest that functional health literacy can now also be included as an influencing factor for the quality of postoperative recovery,” wrote the authors, who added that FHL should be considered a relevant factor in considering how to best optimize recovery for patients undergoing day surgery.
In a linked commentary,2 Jesse P Wright, MD; Kelvin Moses, MD, PhD; and Kamran Idrees, MD, MSCI, MMHC, wrote that “we question if patients are able to equally discern the difference in the questioning in the quality of recovery and [quality of life] questionnaires” used in the study, but said that “The findings in this ambulatory setting mirror findings by our group where we reported an association of low health literacy with various postoperative metrics, including increased hospital length of stay and use of discharge resources in patients undergoing surgical procedures.”
The commentary’s authors say that investment in development of validated tools to measure FHL will generate the empirical data necessary to develop and use appropriate health literacy interventions.
References
1. Nyman MH, Nilsson U, Dahlberg K, Jaensson M. Association between functional health literacy and postoperative recovery, health care contacts, and health-related quality of life among patients undergoing day surgery, secondary analysis of a randomized clinical trial [Published online April 25, 2018]. JAMA Surg. doi: 10.1001/jamasurg.2018.0672.
2. Wright JP, Moses K, Idrees K. Making the case for importance of health literacy in the surgical population. [Published online April 25, 2018]. JAMA Surg. doi: 10.1001/jamasurg.2018.0673.
Dr Chakra Chaulagain: PFS Is the "Bare Minimum," but OS Is Ideal for Choosing Between MM Therapies
March 28th 2024Response rates are important when choosing between therapies to treat multiple myeloma (MM), but improvement overall survival (OS) is the ideal, said Chakra Chaulagain MD, FACP, hematologist/oncologist, Maroone Cancer Center of Cleveland Clinic Florida.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Alopecia Areata Impacts Patient Perception, Quality of Life
March 27th 2024Patients with alopecia areata (AA) often perceive their hair loss as more severe than dermatologists do, leading to increased emotional and social problems. This study highlights the importance of understanding patient perception for better treatment and improved quality of life.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More